AngioDynamics Liabilities 2024

AngioDynamics Aktienanalyse

What does AngioDynamics do?

AngioDynamics Inc is a leading provider of medical devices and solutions for the treatment of vascular diseases and cancer. The company was founded in 1988 and is headquartered in Latham, New York. Over the years, AngioDynamics has evolved into a conglomerate through several acquisitions and partnerships, specializing in various areas. The key divisions include Vascular Access Solutions, Oncology Solutions, and Peripheral Vascular Solutions. AngioDynamics focuses on developing and manufacturing innovative technologies that improve medical care and promote patient health. The company develops and distributes a wide range of medical devices and procedures to treat diseases such as cancer, venous diseases, and thrombosis. In the Vascular Access Solutions division, AngioDynamics offers a wide range of devices for establishing vascular access, which are necessary for the treatment of serious illnesses. This includes port systems and catheters that facilitate access to the body's vascular system. AngioDynamics' Oncology Solutions provide targeted cancer treatment options, including ultrasound-controlled radiofrequency ablation systems and fusion biopsy systems. The development of innovative diagnostic and treatment options is a focus of AngioDynamics. A majority of AngioDynamics' products are in the Peripheral Vascular Solutions division. Here, the company develops devices and procedures for the treatment of peripheral vascular diseases such as varicose veins or chronic venous insufficiency. This includes procedures like laser and radiofrequency treatments that can be performed minimally invasively. AngioDynamics has gained an excellent reputation in the medical industry due to its high-quality products, innovative technologies, and close collaboration with medical professionals. The company places great emphasis on providing optimal care to every patient and therefore serves hospitals, clinics, and medical practices worldwide. Over the years, AngioDynamics has become a leading provider of medical devices and solutions for the treatment of vascular diseases and cancer. The company has built a broad customer base worldwide and has become an important player in the medical industry due to the quality and innovation of its products. AngioDynamics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing AngioDynamics's Liabilities

AngioDynamics's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating AngioDynamics's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing AngioDynamics's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

AngioDynamics's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in AngioDynamics’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about AngioDynamics stock

What is the level of liabilities of AngioDynamics this year?

AngioDynamics has a debt balance of 112.08 M USD this year.

What were the liabilities of AngioDynamics compared to the previous year?

The liabilities of AngioDynamics have increased by -12.64% dropped compared to the previous year.

What are the consequences of high debt for investors of AngioDynamics?

High liabilities can pose a risk for investors of AngioDynamics, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in AngioDynamics?

Low liabilities mean that AngioDynamics has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of AngioDynamics affect the company?

An increase in liabilities of AngioDynamics can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of AngioDynamics affect the company?

A decrease in the liabilities of AngioDynamics can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of AngioDynamics?

Some factors that can influence the liabilities of AngioDynamics include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of AngioDynamics so important for investors?

The liabilities of AngioDynamics are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can AngioDynamics take to modify the liabilities?

To change its liabilities, AngioDynamics can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does AngioDynamics pay?

Over the past 12 months, AngioDynamics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, AngioDynamics is expected to pay a dividend of 0 USD.

What is the dividend yield of AngioDynamics?

The current dividend yield of AngioDynamics is .

When does AngioDynamics pay dividends?

AngioDynamics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of AngioDynamics?

AngioDynamics paid dividends every year for the past 0 years.

What is the dividend of AngioDynamics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is AngioDynamics located?

AngioDynamics is assigned to the 'Health' sector.

Wann musste ich die Aktien von AngioDynamics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of AngioDynamics from 10/6/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/6/2024.

When did AngioDynamics pay the last dividend?

The last dividend was paid out on 10/6/2024.

What was the dividend of AngioDynamics in the year 2023?

In the year 2023, AngioDynamics distributed 0 USD as dividends.

In which currency does AngioDynamics pay out the dividend?

The dividends of AngioDynamics are distributed in USD.